Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marianne Manchester

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Plos Pathogens|October 5, 2005
Why provide an opinions section in PLoS pathogens?Marianne Manchester
Future Microbiology|February 12, 2009
Anti-toxin antibodies in prophylaxis and treatment of inhalation anthraxAnette Schneemann, Marianne Manchester
Advances in Virus Research|April 24, 2017
Metabolomics: Strategies to Define the Role of Metabolism in Virus Infection and PathogenesisMarianne Manchester, Anisha Anand
Advanced Drug Delivery Reviews|November 23, 2006
Virus-based nanoparticles (VNPs): platform technologies for diagnostic imagingMarianne Manchester, Pratik Singh
Biomacromolecules|September 12, 2012
Differential uptake of chemically modified cowpea mosaic virus nanoparticles in macrophage subpopulations present in inflammatory and tumor microenvironmentsArpita Agrawal, Marianne Manchester
Biomacromolecules|March 14, 2009
PEGylated viral nanoparticles for biomedicine: the impact of PEG chain length on VNP cell interactions in vitro and ex vivoNicole F Steinmetz, Marianne Manchester
Current Opinion in Chemical Biology|November 2, 2010
Chemically modified viruses: principles and applicationsKristopher J Koudelka, Marianne Manchester
Molecular Pharmaceutics|August 22, 2012
Endocytic uptake pathways utilized by CPMV nanoparticlesEmily M Plummer, Marianne Manchester
Scientific Reports|February 23, 2012
Inhibition of fatty acid metabolism ameliorates disease activity in an animal model of multiple sclerosisLeah P Shriver, Marianne Manchester
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|September 28, 2010
Viral nanoparticles and virus-like particles: platforms for contemporary vaccine designEmily M Plummer, Marianne Manchester
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Plos Pathogens|October 5, 2005
Why provide an opinions section in PLoS pathogens?Marianne Manchester
Future Microbiology|February 12, 2009
Anti-toxin antibodies in prophylaxis and treatment of inhalation anthraxAnette Schneemann, Marianne Manchester
Advances in Virus Research|April 24, 2017
Metabolomics: Strategies to Define the Role of Metabolism in Virus Infection and PathogenesisMarianne Manchester, Anisha Anand
Advanced Drug Delivery Reviews|November 23, 2006
Virus-based nanoparticles (VNPs): platform technologies for diagnostic imagingMarianne Manchester, Pratik Singh
Biomacromolecules|September 12, 2012
Differential uptake of chemically modified cowpea mosaic virus nanoparticles in macrophage subpopulations present in inflammatory and tumor microenvironmentsArpita Agrawal, Marianne Manchester
Biomacromolecules|March 14, 2009
PEGylated viral nanoparticles for biomedicine: the impact of PEG chain length on VNP cell interactions in vitro and ex vivoNicole F Steinmetz, Marianne Manchester
Current Opinion in Chemical Biology|November 2, 2010
Chemically modified viruses: principles and applicationsKristopher J Koudelka, Marianne Manchester
Molecular Pharmaceutics|August 22, 2012
Endocytic uptake pathways utilized by CPMV nanoparticlesEmily M Plummer, Marianne Manchester
Scientific Reports|February 23, 2012
Inhibition of fatty acid metabolism ameliorates disease activity in an animal model of multiple sclerosisLeah P Shriver, Marianne Manchester
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|September 28, 2010
Viral nanoparticles and virus-like particles: platforms for contemporary vaccine designEmily M Plummer, Marianne Manchester
Pageof 7